$CHYM

DST Global Advisors Ltd (Zinonos Despoina) sold $61.4M of CHYM (indirect holdings)

DST Global Advisors Ltd sold 1,855,958 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $33.09 ($33.06–$33.51, $61.41M total) across 21 trades over 2026-08-24 to 2026-08-25. Filed jointly with Cardew Services Ltd (10% owner), Galileo (PTC) Ltd (10% owner) and Zinonos Despoina (10% owner).

Original reporting
SEC EDGAR · DST Global Advisors Ltd, Cardew Services Ltd, Galileo (PTC) Ltd, Zinonos Despoina
Published Aug 26, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 8:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Bearish
medium confidence
Mentioned
$CHYM
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMBearishMed
01

Why it matters

The disclosed sale reduces a major insider's holding, which may be interpreted as a lack of confidence in near‑term performance.

02

Market read

First‑report insider sale of over $60M; traders may reassess short‑term outlook for CHYM.

03

What to watch

Potential upcoming earnings or product news could offset the negative signal from the insider sell.

Relevance 8/10Novelty 8/10Timing: post‑market filing on 2026‑08‑26

Background

DST Global Advisors Ltd and related entities filed a Form 4 reporting an open‑market sale of Chime Financial shares.

Company-level read

Ticker impact

$CHYMBearishMedium confidence
Context

Form 4 disclosed DST Global Advisors sold ~1.86M shares of Chime Financial for $61.4M, reducing its stake to 380,298 shares.

Expected impact

Possible short-term downside pressure; traders may consider selling or reducing exposure.

Evidence & confidence

Large dollar amount and insider's 10% ownership make the sale material; no 10b5-1 plan suggests discretionary action.

Market effects

Insider sell may weigh on fintech sector sentiment, especially peer digital‑bank stocks.

Limited to US markets where CHYM trades; no broader regional effect.

Minimal global impact beyond investors tracking US fintech equities.

Counterpoint

The sale could be a portfolio rebalancing unrelated to fundamentals; price may remain stable.

Key entities

  • Chime Financial, Inc.

    US‑listed fintech firm (ticker CHYM).

  • DST Global Advisors Ltd

    10% owner filing the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock gaining today?

Chime Financial (CHYM) stock rose 1.5% in pre-market trading after Deutsche Bank upgraded it to Buy and raised its price target to $35. The bank cited strong Q2 2026 results, including 27% revenue growth and GAAP profitability, as well as growth in MyPay and Chime Prime. The upgrade also boosted FY27 adjusted EBITDA estimates by $71 million.

$CHYMMed

Deutsche Bank Upgrades Chime (CHYM) to Buy, Raises Price Target

Deutsche Bank upgraded Chime Financial Inc (CHYM) to Buy, raising its price target to $35. The bank cited strong product momentum and market expansion potential, particularly with MyPay and Chime Prime. Chime's P/S ratio is 4.85, above its historical and industry medians, reflecting growth expectations. Insider activity shows significant net selling, while institutional ownership trends are mixed.

$CHYMMed

Chime Financial Slides as Recent Insider Sales Likely Weigh on Shares

Chime Financial (CHYM) shares fell 7.5% today, likely due to recent insider and major-holder sales, including 3.2 million shares sold by DST Global and 447,637 shares by director James Feuille. The decline follows Chime's announcement of a $590 million bank acquisition, with no new negative updates reported. Analysts' median price target for CHYM is $28.0.